Pyrazinamide: An Effective Agent for the Treatment of Leishmaniasis
A promising alternative therapy to Leishmaniasis that may also cause collateral immuno-stimulation.
Background:
Leishmaniasis is a disease that has been neglected by most of the developed world until now, despite the fact that it is the 2nd most prevalent parasitic disease after malaria in global disease burden. Formerly considered to be a tropical...
Published: 5/13/2025
|
Inventor(s): John Welch, Susana Mendez, Michael Cynamon
Keywords(s): Chagas disease, Leishmania major, leishmaniasis, pyrazinamide, tripanosomes
Category(s): Technology Classifications > Therapeutics and Vaccines, Campus > University at Albany
|